SCHEMBL15046049

SCHEMBL15046049

CNc1ncnc2c1ncn2CCOC[PH](=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 3/20 0.53
PDE4A P27815 3/20 0.48
PDE4B Q07343 3/20 0.48
PDE4C Q08493 3/20 0.48
PDE4D Q08499 3/20 0.48
YTHDC1 Q96MU7 2/20 0.48
PDE5A O76074 2/20 0.45
PDE1A P54750 2/20 0.45
PDE1B Q01064 2/20 0.45
PDE3B Q13370 2/20 0.45
PDE1C Q14123 2/20 0.45
PDE3A Q14432 2/20 0.45
SLC22A6 Q4U2R8 2/20 0.45
FGFR1 P11362 1/20 0.45
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPK1 P28482 1/20 0.40
TMIGD3 P0DMS9 2/20 0.40
ADORA2A P29274 2/20 0.40
ADORA1 P30542 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3304318 0.81 FGFR1 (0.66) SLC22A6FGFR1ADORA2AADORA1ADCY5
SCHEMBL15045868 0.81 FGFR1 (0.69) P2RY1PDE4APDE4BPDE4CPDE4D
SCHEMBL19242632 0.76 YTHDC1 (0.61) P2RY1PDE4APDE4BPDE4CPDE4D
SCHEMBL12179919 0.74 YTHDC1 (0.61) P2RY1PDE4APDE4BPDE4CPDE4D
SCHEMBL8467638 0.72 ADORA2A (0.56) P2RY1PDE4APDE4BPDE4CPDE4D
SCHEMBL18548917 0.72 YTHDC1 (0.62) P2RY1PDE4APDE4BPDE4CPDE4D
SCHEMBL17625477 0.71 FGFR1 (0.34) P2RY1SLC22A6FGFR1POLA1POLG
SCHEMBL17625419 0.70 HSP90AB1 (0.46) SLC22A6FGFR1POLA1POLG
SCHEMBL13234957 0.69 P2RY1 (0.61) P2RY1PDE4APDE4BPDE4CPDE4D
SCHEMBL15257680 0.69 FGFR1 (0.65) P2RY1SLC22A6FGFR1ABCB11POLA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013090420-A2 FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2013-06-20 WO disclosed